Preparing Research Experience

Skip to main content

Lab Tested

CJC-1295 / Ipamorelin 10 MG research product

Quality documentationBrowse available batch documentation in our COA library.

Hormonal Sexual Health Research

CJC-1295 / Ipamorelin 10 MG

(MODIFIED GRF (1-29) / IPAMORELIN)

In Stock

Everwell Peptides CJC-1295 / Ipamorelin 10MG combines 5MG CJC-1295 with 5MG Ipamorelin for controlled research into complementary growth-hormone signaling pathways. Laboratory studies examine endocrine communication, recovery markers, metabolic regulation, and cellular-response patterns. For research use only.

Format
Vials
Research Qty.
10 MG
Purity
Documentation Varies
Product ID
EW-0008
Unit Price$99.99
1 Item Total$99.99
Browse COAs

Available to order. Inventory is reserved only after payment.

Research use only. Not for human or animal consumption, ingestion, administration, diagnostic use or therapeutic use.

Research Product Information

CJC-1295 / Ipamorelin Details

Review identification, documentation and recommended laboratory handling information before ordering.

01

Research Overview

About CJC-1295 / Ipamorelin

Everwell Peptides CJC-1295 / Ipamorelin 10MG combines 5MG CJC-1295 with 5MG Ipamorelin for controlled research into complementary growth-hormone signaling pathways. Laboratory studies examine endocrine communication, recovery markers, metabolic regulation, and cellular-response patterns. For research use only.

Everwell Peptides supplies this material strictly for research and analytical applications. Product information is provided for identification and documentation and is not a claim of clinical efficacy.

02

Product Specifications

10 MG Research Product

Product
CJC-1295 / Ipamorelin
Quantity
10 MG
Type
Vials
Documentation
See COA catalog
03

Laboratory Handling

Storage & Care

  • Keep sealed in a cool, dry and controlled laboratory environment.
  • Protect from direct light, heat and repeated temperature changes.
  • Follow batch documentation and validated facility procedures.
  • Restrict access to qualified research personnel.
0